Skip to main content
    B

    Biocardia Inc (BCDA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.79
    -0.04 (-4.92%)

    Market Cap: $12.58M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Biocardia Inc (BCDA) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Biocardia are Dare Bioscience (DARE), Cyclerion Therapeutics (CYCN) and Biovie (BIVI). By market cap, Biocardia ranks 8th of the 13 companies on this page; CervoMed (CRVO) is the largest at $25.57M.

    Peer Comparison

    BCDA's revenue growth of -100.0% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Biocardia (BCDA)$12.58MN/AN/A0.0%N/A-100.0%0.00%
    Dare Bioscience Inc (DARE)$12.93MN/A6.4x0.0%N/A499.6%0.00%
    Cyclerion Therapeutics Inc (CYCN)$15.73MN/AN/A0.0%N/A-43.2%0.00%
    Biovie Inc (BIVI)$12.12MN/AN/A0.0%N/A0.0%0.00%
    Passage Bio Inc (PASG)$13.68MN/AN/A0.0%N/A0.0%0.00%
    CytoMed Therapeutics Limited Ordinary Shares (GDTC)$9.90MN/A16.4x0.0%-72.3%-15.9%0.00%
    Cardio Diagnostics Holdings Inc (CDIO)$5.59MN/A348.9x0.0%N/A25.7%0.00%
    CervoMed Inc. (CRVO)$25.57MN/AN/A0.0%N/A-99.6%0.00%
    Citius Pharmaceuticals Inc (CTXR)$14.69MN/A1.9x0.0%-84.3%0.0%0.00%
    FibroBiologics, Inc. Common Stock (FBLG)$6.57MN/AN/A0.0%N/A0.0%0.00%
    Cadrenal Therapeutics, Inc. Common Stock (CVKD)$5.39MN/AN/A0.0%N/A0.0%0.00%
    Celularity Inc (CELU)$20.45MN/A1.0x-245.7%N/A-5.3%0.00%
    Collplant Biotechnologies Ltd (CLGN)$14.27MN/A21.0x0.0%N/A-39.7%0.00%
    Peer median$13.30MN/A11.4x0.0%-78.3%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Biocardia, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Dare Bioscience Inc (DARE)
    Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States.
    DARE competitors
    Cyclerion Therapeutics Inc (CYCN)
    Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development...
    Biovie Inc (BIVI)
    BioVie Inc., a clinical-stage biotechnology company, is dedicated to the discovery, development, and commercialization of drug therapies in the United States.
    BIVI competitors
    Passage Bio Inc (PASG)
    Passage Bio, Inc., a genetic drug company, develops transformative therapies for rare monogenic central nervous system (CNS) diseases.
    PASG competitors
    CytoMed Therapeutics Limited Ordinary Shares (GDTC)
    CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human...
    Cardio Diagnostics Holdings Inc (CDIO)
    Cardio Diagnostics Holdings Inc (CDIO) is a pioneering biotechnology firm focused on enhancing cardiovascular health through innovative diagnostic solutions.
    CDIO competitors
    CervoMed Inc. (CRVO)
    CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases.
    CRVO competitors
    Citius Pharmaceuticals Inc (CTXR)
    Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products.
    CTXR competitors
    FibroBiologics, Inc. Common Stock (FBLG)
    FibroBiologics, Inc. is an innovative biotechnology company dedicated to advancing regenerative medicine through its proprietary fibroblast cell technology...
    FBLG competitors
    Cadrenal Therapeutics, Inc. Common Stock (CVKD)
    Cadrenal Therapeutics, Inc. (CVKD) is a clinical-stage biopharmaceutical firm dedicated to developing groundbreaking therapies for renal diseases and associated...
    CVKD competitors
    Celularity Inc (CELU)
    Celularity Inc. is a pioneering biotechnology company focused on regenerative medicine through its innovative cellular products derived from the placenta.
    CELU competitors
    Collplant Biotechnologies Ltd (CLGN)
    CollPlant Biotechnologies Ltd., an aesthetic and regenerative medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs...
    CLGN competitors

    Frequently Asked Questions About BCDA

    Who are Biocardia's main competitors?

    The companies most similar to Biocardia include Dare Bioscience (DARE), Cyclerion Therapeutics (CYCN), Biovie (BIVI), Passage Bio (PASG) and CytoMed Therapeutics Limited Ordinary Shares (GDTC), listed from the closest match.

    Who is Biocardia's biggest competitor?

    CervoMed (CRVO) is the largest of the similar companies at $25.57M; Dare Bioscience (DARE) is the closest match by business profile, size, sector and industry.

    How does BCDA stock compare with its competitors?

    BCDA's net margin is 0.0% against a peer median of 0.0%.

    Which of Biocardia's competitors pays a higher dividend?

    Biocardia pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Biocardia bigger than its competitors?

    No. Biocardia is 8th by market cap among the 13 companies on this page; the largest is CervoMed (CRVO) at $25.57M.